![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.moneycontrol.com/news/business/alembic-gets-usfda-nod-for-ointment-to-treat-skin-disease-4556861.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211175
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-March-29-2017-1490767993.pdf
http://www.prnewswire.com/news-releases/slayback-pharma-announces-the-final-approval-and-launch-of-generic-zovirax-acyclovir-ointment-5-300383519.html
https://www.pharmacompass.com/pdf/news/fougera-pharms-incs-generic-acyclovir-approved-in-us-as-an-antiviral-medication-1463220400.pdf
http://www.in-pharmatechnologist.com/Processing/Novartis-consolidating-NY-dermatology-sites-but-says-no-jobs-at-risk